Continuous Glucose Monitoring Alert Settings and Glycemic Control in People With Diabetes - Report - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Impact of Custom Alert Settings in Continuous Glucose Monitoring on Glycemic Management in Diabetic Patients

  • By

  • Yaguang Zheng

  • Stephen B. Johnson

  • Eduardo Iturrate

  • Bei Wu

  • Heng Huang

  • William Small

  • Susan Zweig

  • Rozalina G. McCoy

  • September 23, 2026

Share

Clinical Report: Impact of Custom Alert Settings in Continuous Glucose Monitoring

Overview

This study evaluates the impact of customizable alert settings in continuous glucose monitoring (CGM) on glycemic management among patients with type 1 and type 2 diabetes. Findings indicate that activation of high-glucose alerts is associated with improved glycemic outcomes.

Background

Continuous glucose monitoring (CGM) is a standard of care for individuals with type 1 and insulin-treated type 2 diabetes, providing real-time glucose data and alerts. Understanding the relationship between alert settings and glycemic control is crucial for optimizing CGM use. This study aims to clarify how different alert configurations affect glycemic outcomes.

Data Highlights

Alert TypeOutcomeEffect
Low-Glucose AlertTime Below Range (TBR) 54-70 mg/dLReduced
High-Glucose AlertAverage GlucoseLowered
High-Glucose AlertTime in Range (TIR)Increased

Key Findings

  • Activation of low-glucose alerts was associated with reduced TBR from 54 to 70 mg/dL.
  • High-glucose alert activation correlated with lower average glucose and GMI, and increased TIR.
  • Among T1D patients, high-alert activation was linked to TIR and TBR from 54 to 70 mg/dL.
  • Low-alert thresholds showed mixed associations, particularly concerning hypoglycemia measures.

Clinical Implications

Understanding the specific associations between alert types and glycemic outcomes can guide better patient education and alert configuration.

Conclusion

The study demonstrates that high-alert configurations can lead to improved glycemic outcomes, particularly in patients with type 1 diabetes.

Related Resources & Content

  1. JAMA Network Open, 2023 -- Implementing Continuous Glucose Monitoring Alerts in Clinical Settings—Moving Beyond Efficacy
  2. Frontiers in Endocrinology, 2023 -- Impact of Continuous Glucose Monitoring on Adverse In-Hospital Outcomes in Critically Ill Patients: A Propensity Score-Matched Analysis
  3. JAMA Network Open, 2023 -- Primary Care–Initiated Continuous Glucose Monitoring in Adults With Insulin-Treated Diabetes
  4. Diabetes Technology: Standards of Care in Diabetes—2026
  5. MDSpire News — Continuous Glucose Monitors Overestimate Glycemia, Study Finds
  6. 7. Diabetes Technology: Standards of Care in Diabetes—2026
  7. Comparing real-time and intermittently scanned continuous glucose monitoring in adults with type 1 diabetes (ALERTT1): a 6-month, prospective, multicentre, randomised controlled trial.

Original Source(s)

Related Content